Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CORE MOLDING TECHNOLOGIES INCCMT · Entity 6229 | Director | March 11, 2026 | March 13, 2026 |
| LIBBEY INCLBY · Entity 13145 | VP, General Mgr US & Canada | May 31, 2017 | June 01, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CORE MOLDING TECHNOLOGIES INC
Report date March 11, 2026 · Filed March 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,435 |
Reported balance
After 2026-03-11 transaction · row 1
1 source rowRow 1 · 2026-03-11 · Grant · Acquired 4,179 · Balance 14,435 |
LIBBEY INC
Report date May 31, 2017 · Filed June 01, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,000 |
Reported balance
After 2017-05-31 transaction · row 1
1 source rowRow 1 · 2017-05-31 · Purchase · Acquired 10,000 · Balance 10,000 F1: This transaction was executed in multiple transactions at per share prices ranging from $8.28 to $8.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Restricted Stock UnitsSEC Table I · non-derivative | Direct | 39,392 |
Reported balance
Holding disclosure · report date 2017-05-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 39,392 |
| NQ - Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.00 · Expires 2021-02-10 | Direct | 7,000 |
Reported balance
Holding disclosure · report date 2017-05-31 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 7,000 F2: The options become exercisable for 25% of the shares on each of the first, second, third, and fourth anniversary dates. |
| NQ - Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.02 · Expires 2024-02-24 | Direct | 6,582 |
Reported balance
Holding disclosure · report date 2017-05-31 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 6,582 F2: The options become exercisable for 25% of the shares on each of the first, second, third, and fourth anniversary dates. |
| NQ - Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.96 · Expires 2022-08-01 | Direct | 3,597 |
Reported balance
Holding disclosure · report date 2017-05-31 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 3,597 F2: The options become exercisable for 25% of the shares on each of the first, second, third, and fourth anniversary dates. |
| NQ - Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.47 · Expires 2020-12-31 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2017-05-31 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 20,000 F3: Stock option vests 100% on 12/31/2013. |
| NQ - Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.13 · Expires 2020-02-11 | Direct | 6,000 |
Reported balance
Holding disclosure · report date 2017-05-31 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 6,000 F2: The options become exercisable for 25% of the shares on each of the first, second, third, and fourth anniversary dates. |
| NQ - Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.60 · Expires 2027-03-01 | Direct | 15,329 |
Reported balance
Holding disclosure · report date 2017-05-31 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 15,329 |
| NQ - Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.13 · Expires 2026-02-25 | Direct | 21,486 |
Reported balance
Holding disclosure · report date 2017-05-31 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 21,486 |
| NQ - Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.35 · Expires 2018-02-15 | Direct | 3,200 |
Reported balance
Holding disclosure · report date 2017-05-31 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 3,200 F2: The options become exercisable for 25% of the shares on each of the first, second, third, and fourth anniversary dates. |
| NQ - Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.02 · Expires 2023-02-22 | Direct | 7,918 |
Reported balance
Holding disclosure · report date 2017-05-31 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 7,918 F2: The options become exercisable for 25% of the shares on each of the first, second, third, and fourth anniversary dates. |
| NQ - Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.95 · Expires 2022-02-17 | Direct | 7,500 |
Reported balance
Holding disclosure · report date 2017-05-31 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 7,500 F2: The options become exercisable for 25% of the shares on each of the first, second, third, and fourth anniversary dates. |
| NQ - Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.06 · Expires 2025-03-02 | Direct | 6,340 |
Reported balance
Holding disclosure · report date 2017-05-31 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 6,340 F4: The options become exercisable for 25% of the shares on February 17th of each of 2016, 2017, 2018 and 2019 provided the grantee remains continuously employed by the Company as of those respective dates. |
| NQ - Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.01 · Expires 2019-02-27 | Direct | 7,000 |
Reported balance
Holding disclosure · report date 2017-05-31 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 7,000 F2: The options become exercisable for 25% of the shares on each of the first, second, third, and fourth anniversary dates. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple transactions at per share prices ranging from $8.28 to $8.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: The options become exercisable for 25% of the shares on each of the first, second, third, and fourth anniversary dates.
F3: Stock option vests 100% on 12/31/2013.
F4: The options become exercisable for 25% of the shares on February 17th of each of 2016, 2017, 2018 and 2019 provided the grantee remains continuously employed by the Company as of those respective dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 11, 2026 Filed Mar 13, 2026 17:48 UTC | CORE MOLDING TECHNOLOGIES INC CMT · Entity 6229 | GrantCommon Stock | 4,179 | $0.00 | $0.00 |
DisclosureSEC source: 0001636007-26-000003 · wk-form4_1773424084.xml · nonDerivative · entry 1 Minarro Salvador · CIK 0001636007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,435 Read SEC document |
| March 11, 2025 Filed Mar 14, 2025 21:29 UTC | CORE MOLDING TECHNOLOGIES INC CMT · Entity 6229 | GrantCommon Stock | 6,150 | $12.81 | $78,781.50 |
DisclosureSEC source: 0001026655-25-000017 · wk-form4_1741987788.xml · nonDerivative · entry 1 Minarro Salvador · CIK 0001636007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,256 Read SEC document |
| March 07, 2024 Filed Mar 8, 2024 18:12 UTC | CORE MOLDING TECHNOLOGIES INC CMT · Entity 6229 | GrantCommon Stock | 4,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001026655-24-000015 · wk-form4_1709921525.xml · nonDerivative · entry 1 Minarro Salvador · CIK 0001636007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,106 Read SEC document |
| May 31, 2017 Filed Jun 1, 2017 07:08 UTC | LIBBEY INC LBY · Entity 13145 | PurchaseCommon Stock | 10,000 | $8.43 | $84,260.00 |
DisclosureSEC source: 0000902274-17-000107 · wf-form4_149631527217765.xml · nonDerivative · entry 1 Minarro Salvador · CIK 0001636007 · VP, General Mgr US & Canada 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: This transaction was executed in multiple transactions at per share prices ranging from $8.28 to $8.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:31 UTC | LIBBEY INC LBY · Entity 13145 | GrantNQ - Stock Option (Right to Buy) · Derivative | 15,329 | $13.60 Strike: $13.60 | $208,474.40 |
DisclosureSEC source: 0000902274-17-000041 · wf-form4_148859468775114.xml · derivative · entry 2 Minarro Salvador · CIK 0001636007 · VP, General Mgr US & Canada 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,329 Underlying: Common Stock · 15,329 shares Expires 2027-03-01 F2 · derivative.exercise_date: The options become exercisable for 25% of the shares on February 17th of each of 2018, 2019, 2020 and 2021 provided the grantee remains continuously employed by the Company as of those respective dates. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:31 UTC | LIBBEY INC LBY · Entity 13145 | GrantRestricted Stock Units | 7,579 | $13.60 | $103,074.40 |
DisclosureSEC source: 0000902274-17-000041 · wf-form4_148859468775114.xml · nonDerivative · entry 1 Minarro Salvador · CIK 0001636007 · VP, General Mgr US & Canada 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,392 F1 · shares: Restricted stock units will vest 25% on February 17th of each of 2018, 2019, 2020 and 2021 provided the grantee remains continuously employed by the Company as of those respective dates. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 17:03 UTC | LIBBEY INC LBY · Entity 13145 | Tax withholdingRestricted Stock Units | 478 | $16.25 | $7,767.50 |
DisclosureSEC source: 0000902274-17-000027 · wf-form4_148831935687128.xml · nonDerivative · entry 1 Minarro Salvador · CIK 0001636007 · VP, General Mgr US & Canada 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,813 F1 · shares: Reflects shares withheld to satisfy tax withholding obligations on restricted stock units that vested. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 16:54 UTC | LIBBEY INC LBY · Entity 13145 | Tax withholdingRestricted Stock Units | 562 | $17.25 | $9,694.50 |
DisclosureSEC source: 0000902274-17-000018 · wf-form4_148797325308942.xml · nonDerivative · entry 1 Minarro Salvador · CIK 0001636007 · VP, General Mgr US & Canada 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,291 F1 · shares: Reflects shares withheld to satisfy tax withholding obligations on restricted stock units that vested. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 16:52 UTC | LIBBEY INC LBY · Entity 13145 | Tax withholdingRestricted Stock Units | 2,451 | $17.77 | $43,554.27 |
DisclosureSEC source: 0000902274-17-000008 · wf-form4_148771394117571.xml · nonDerivative · entry 1 Minarro Salvador · CIK 0001636007 · VP, General Mgr US & Canada 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,853 F1 · shares: Reflects shares withheld to satisfy tax withholding obligations on restricted stock units that vested. F2 · balance_after: Includes: 823 restricted stock units remaining in the 8/1/2012 grant of 4,918 RSUs; 4,243 restricted stock units remaining in the 2/22/2013 grant of 6,939 RSUs that vest 25% on each of the 1st, 2nd, 3rd & 4th anniversary dates; 4,737 restricted stock units remaining in the 2/24/2014 grant of 5,781 RSUs that vest 25% on each of the 1st, 2nd, 3rd & 4th anniversary dates; 3,865 restricted stock units remaining in the 3/2/2015 grant of 4,695 RSUs that vest 25% on each of the 1st, 2nd, 3rd & 4th anniversary dates; 9,876 restricted stock units remaining in the 3/2/2015 RSU grant of 12,000 RSUs that vest 25% on February 17th of each of 2016, 2017, 2018 and 2019; and 9,309 restricted stock units remaining in the 2/25/16 grant of 10,158 RSUs that vest 25% on February 17th of each of 2017, 2018, 2019 and 2020, all vesting dates provided the grantee remains continuously employed by the Company as of those respective dates. Read SEC document |
| December 19, 2016 Filed Dec 20, 2016 17:18 UTC | LIBBEY INC LBY · Entity 13145 | Exercise / conversionNQ - Stock Option (Right to Buy) · Derivative | 2,882 | $12.80 Strike: $12.80 | $36,889.60 |
DisclosureSEC source: 0000902274-16-000396 · wf-form4_148227228194295.xml · derivative · entry 9 Minarro Salvador · CIK 0001636007 · VP, General Mgr US & Canada 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 2,882 shares Expires 2017-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The options become exercisable for 25% of the shares on each of the first, second, third, and fourth anniversary dates. Read SEC document |
| December 19, 2016 Filed Dec 20, 2016 17:18 UTC | LIBBEY INC LBY · Entity 13145 | SaleCommon Shares | 2,882 | $20.38 | $58,735.16 |
DisclosureSEC source: 0000902274-16-000396 · wf-form4_148227228194295.xml · nonDerivative · entry 2 Minarro Salvador · CIK 0001636007 · VP, General Mgr US & Canada 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The common stock covered by this Form 4 was sold under a plan, adopted on November 18, 2016, in compliance with Rules 10b5-1 under the Securities Act of 1934, as amended. Read SEC document |
| December 19, 2016 Filed Dec 20, 2016 17:18 UTC | LIBBEY INC LBY · Entity 13145 | Exercise / conversionCommon Shares | 2,882 | $12.80 | $36,889.60 |
DisclosureSEC source: 0000902274-16-000396 · wf-form4_148227228194295.xml · nonDerivative · entry 1 Minarro Salvador · CIK 0001636007 · VP, General Mgr US & Canada 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The common stock covered by this Form 4 was sold under a plan, adopted on November 18, 2016, in compliance with Rules 10b5-1 under the Securities Act of 1934, as amended. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.